Table 1.
Baseline ICH characteristics of patients with poor vs favorable 6-month mRS
| All N = 44 | 6-month poor outcome N = 28 | 6-month favorable outcome N = 16 | P-value | |
| Age: mean (SD) | 64 (14) | 68 (12) | 57 (13) | 0.01 |
| Female: N (%) | 25 (57) | 15 (54) | 10 (63) | 0.75 |
| Race/Ethnicity: N (%) | 0.26 | |||
| White | 13 (30) | 9 (32) | 4 (25) | |
| Black | 13 (30) | 5 (18) | 8 (50) | |
| Asian | 3 (7) | 2 (7) | 1 (6) | |
| Hispanic | 9 (20) | 7 (25) | 2 (13) | |
| Other/Unknown | 6 (14) | 5 (18) | 1 (6) | |
| Medical history: N (%) | ||||
| Dyslipidemia | 13 (30) | 10 (37) | 3 (19) | 0.31 |
| Hypertension | 36 (82) | 21 (75) | 15 (94) | 0.22 |
| Diabetes | 9 (20) | 6 (21) | 3 (19) | 1.00 |
| Coronary artery disease | 6 (14) | 5 (19) | 1 (6) | 0.39 |
| Anti-platelet medication: N (%) | 18 (41) | 13 (46) | 5 (31) | 0.36 |
| Clinical/radiographic | ||||
| Baseline ICH Volume (mL): median (IQR) | 23 (15–46) | 28 (16–49) | 18 (6–37) | 0.14 |
| IVH: N (%) | 20 (45) | 13 (46) | 7 (44) | 1.00 |
| ICH Score: median (IQR) | 2 (1–3) | 3 (2–3) | 1 (0–3) | 0.01 |
ICH: intracerebral hemorrhage; mRS: Modified Rankin Scale (poor: 4–6; favorable: 0–3); SD: standard deviation; IQR: interquartile range; IVH: intraventricular hemorrhage.